Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ivy Carroll

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Frontiers in Pharmacology|July 26, 2018
A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336F Ivy Carroll, Thomas R Kosten, Jeffrey J Buda, et al.
Journal of Medicinal Chemistry|May 27, 2005
Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compoundsF Ivy Carroll, Sameer Tyagi, Bruce E Blough, et al.
European Journal of Organic Chemistry|August 25, 2020
Synthesis of Enantiopure PZM21, A Novel Biased Agonist of the Mu-Opioid ReceptorDavid Perrey, Dehui Zhang, Thuy Nguyen, et al.
Pharmacology, Biochemistry, and Behavior|September 27, 2008
Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in ratsMark G LeSage, David Shelley, Jason T Ross, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2006
Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeysLeonard L Howell, F Ivy Carroll, John R Votaw, et al.
European Journal of Pharmacology|November 13, 2003
Structural and functional probing of the biogenic amine transporters by fluorescence spectroscopySøren G F Rasmussen, Erika M Adkins, F Ivy Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2007
Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in ratsAllison T Knoll, Edward G Meloni, James B Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 6, 2012
Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTicAshlee Van't Veer, Jessica M Yano, F Ivy Carroll, et al.
Pharmacology, Biochemistry, and Behavior|March 21, 2012
The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) ratsGerald A Deehan, David L McKinzie, F Ivy Carroll, et al.
Annals of the New York Academy of Sciences|May 13, 2020
Designer drugs: a medicinal chemistry perspective (II)F Ivy Carroll, Anita H Lewin, S Wayne Mascarella, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Frontiers in Pharmacology|July 26, 2018
A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336F Ivy Carroll, Thomas R Kosten, Jeffrey J Buda, et al.
Journal of Medicinal Chemistry|May 27, 2005
Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compoundsF Ivy Carroll, Sameer Tyagi, Bruce E Blough, et al.
European Journal of Organic Chemistry|August 25, 2020
Synthesis of Enantiopure PZM21, A Novel Biased Agonist of the Mu-Opioid ReceptorDavid Perrey, Dehui Zhang, Thuy Nguyen, et al.
Pharmacology, Biochemistry, and Behavior|September 27, 2008
Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in ratsMark G LeSage, David Shelley, Jason T Ross, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2006
Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeysLeonard L Howell, F Ivy Carroll, John R Votaw, et al.
European Journal of Pharmacology|November 13, 2003
Structural and functional probing of the biogenic amine transporters by fluorescence spectroscopySøren G F Rasmussen, Erika M Adkins, F Ivy Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 8, 2007
Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in ratsAllison T Knoll, Edward G Meloni, James B Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 6, 2012
Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTicAshlee Van't Veer, Jessica M Yano, F Ivy Carroll, et al.
Pharmacology, Biochemistry, and Behavior|March 21, 2012
The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) ratsGerald A Deehan, David L McKinzie, F Ivy Carroll, et al.
Annals of the New York Academy of Sciences|May 13, 2020
Designer drugs: a medicinal chemistry perspective (II)F Ivy Carroll, Anita H Lewin, S Wayne Mascarella, et al.
Pageof 19